EUDAMED Actor registration is mandatory. The MDR/IVDR transition deadlines are behind us. And yet thousands of Chinese manufacturers still don't have an EU Authorised Representative — because most of them haven't exported to Europe yet.
That's the opportunity. But it only exists if you can find those manufacturers at the right moment. The wrong moment is when they already have an AR. The right moment is while they're still building their domestic pipeline — which is exactly what NMPA registration data shows.
The last signal is especially useful for EU ARs. A manufacturer that already navigated FDA registration understands regulatory agents, paid for them, and is more likely to accept the EU AR concept. The live product page shows current evidence-passed inventory, and EU AR buyers specifically get export-ready firms ranked first.
The whole thing is USD 49 for 10 companies or USD 99 for the full current release, delivered within 48 hours of verified payment. There's a 7-day replacement promise for invalid contacts or broken source links.
Want to see the format before spending a dollar? Download the 3-company sample — one complete lead is shown in full.
Download the free sample See the packsA practical tip: don't send the same "we are an EU AR" template to everyone. Open with the specific signal you found — "I noticed your recent NMPA activity in [category]. When you place devices on the EU market, MDR requires an AR established in the EU..." Specificity is what makes a cold email feel like research, not spam.
The manufacturers are out there. The only question is whether you find them before another AR does.